Related references
Note: Only part of the references are listed.FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis
Paola Maderna et al.
FASEB JOURNAL (2010)
The roles of cathelicidin LL-37 in immune defences and novel clinical applications
Anastasia Nijnik et al.
CURRENT OPINION IN HEMATOLOGY (2009)
Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils
Zhifang Zhang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2009)
Intracellular Receptor for Human Host Defense Peptide LL-37 in Monocytes
Neeloffer Mookherjee et al.
JOURNAL OF IMMUNOLOGY (2009)
Airway lipoxin A4 generation and lipoxin A4 receptor expression are decreased in severe asthma
Anna Planaguma et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Mast cell-expressed orphan receptor CCRL2 binds chemerin and is required for optimal induction of IgE-mediated passive cutaneous anaphylaxis
Brian A. Zabel et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Resolvin E1 regulates interleukin 23, interferon-γ and lipoxin A4 to promote the resolution of allergic airway inflammation
Oliver Haworth et al.
NATURE IMMUNOLOGY (2008)
The genetic design of signaling cascades to record receptor activation
Gilad Barnea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Aromatic lipoxin A4 and lipoxin B4 analogues display potent biological activities
Timothy P. O'Sullivan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Mechanisms of disease: Leukotrienes
Marc Peters-Golden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Leukotriene B4 triggers release of the cathelicidin LL-37 from human neutrophils:: novel lipid-peptide interactions in innate immune responses
Min Wan et al.
FASEB JOURNAL (2007)
Resolvin E1 and protectin D1 activate inflammation-resolution programmes
Jan M. Schwab et al.
NATURE (2007)
The lipoxin A4 receptor is coupled to SHP-2 activation -: Implications for regulation of receptor tyrosine kinases
Derick Mitchell et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation
Makoto Arita et al.
JOURNAL OF IMMUNOLOGY (2007)
Differential production of leukotriene B4 or prostaglandin E2 by WKYMVm or serum amyloid A via formyl peptide receptor-like 1
Ha Young Lee et al.
BIOCHEMICAL PHARMACOLOGY (2006)
Involvement of the antimicrobial peptide LL-37 in human atherosclerosis
Kristina Edfeldt et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
Heterogeneous expression of human cathelicidin hCAP18/LL-37 in inflammatory bowel diseases
Juergen Schauber et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2006)
Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability
Hong Qiu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
An antimicrobial cathelicidin peptide, human CAP18/LL-37, suppresses neutrophil apoptosis via the activation of formyl-peptide receptor-like 1 and P2X7
Isao Nagaoka et al.
JOURNAL OF IMMUNOLOGY (2006)
RvE1 protects from local inflammation and osteoclast- mediated bone destruction in periodontitis
H. Hasturk et al.
FASEB JOURNAL (2006)
The lipoxin receptor ALX: Potent ligand-specific and stereoselective actions in vivo
Nan Chiang et al.
PHARMACOLOGICAL REVIEWS (2006)
Induction of keratinocyte migration via transactivation of the epidermal growth factor receptor by the antimicrobial peptide LL-37
S Tokumaru et al.
JOURNAL OF IMMUNOLOGY (2005)
Leukotriene modifiers as potential therapeutics for cardiovascular disease
CD Funk
NATURE REVIEWS DRUG DISCOVERY (2005)
Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1
M Arita et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Leukotrienes: Underappreciated mediators of innate immune responses
M Peters-Golden et al.
JOURNAL OF IMMUNOLOGY (2005)
A novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1β processing and release
A Elssner et al.
JOURNAL OF IMMUNOLOGY (2004)
Defective lipoxin-mediated anti-inflammatory activity in the cystic fibrosis airway
CL Karp et al.
NATURE IMMUNOLOGY (2004)
The C-terminal nonapeptide of mature chemerin activates the chemerin receptor with low nanomolar potency
V Wittamer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Lipoxins inhibit Akt/PKB activation and cell cycle progression in human mesangial cells
D Mitchell et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Review of epidermal growth factor receptor biology
RS Herbst
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor
GS Tjabringa et al.
JOURNAL OF IMMUNOLOGY (2003)
Lipoxin A4 and aspirin-triggered 15-epi-lipoxin A4 inhibit human neutrophil migration:: Comparisons between synthetic 15 epimers in chemotaxis and transmigration with microvessel endothelial cells and epithelial cells
IM Fierro et al.
JOURNAL OF IMMUNOLOGY (2003)
International union of pharmacology - XXXVII. Nomenclature for leukotriene and lipoxin receptors
C Brink et al.
PHARMACOLOGICAL REVIEWS (2003)
The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses
MG Scott et al.
JOURNAL OF IMMUNOLOGY (2002)
Lipoxins are potential endogenous antiinflammatory mediators in asthma
C Bonnans et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Inverse, protean, and ligand-selective agonism: matters of receptor conformation
T Kenakin
FASEB JOURNAL (2001)
Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing
CN Serhan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells
D Yang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Novel pathophysiological role of classical chemotactic peptide receptors and their communications with chemokine receptors
YY Le et al.
IMMUNOLOGICAL REVIEWS (2000)
A second leukotriene B4 receptor, BLT2:: A new therapeutic target in inflammation and immunological disorders
T Yokomizo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Lipoxin A4 analogues inhibit leukocyte recruitment to Porphyromonas gingivalis:: A role for cyclooxygenase-2 and lipoxins in periodontal disease
M Pouliot et al.
BIOCHEMISTRY (2000)
Activation of lipoxin A4 receptors by aspirin-triggered lipoxins and select peptides evokes ligand-specific responses in inflammation
N Chiang et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Neutrophils: Molecules, functions and pathophysiological aspects
V Witko-Sarsat et al.
LABORATORY INVESTIGATION (2000)
Cutting edge: Lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages
C Godson et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
